PL3235494T3 - Preparat transdermalny zawierający donepezil jako składnik aktywny - Google Patents
Preparat transdermalny zawierający donepezil jako składnik aktywnyInfo
- Publication number
- PL3235494T3 PL3235494T3 PL15870365T PL15870365T PL3235494T3 PL 3235494 T3 PL3235494 T3 PL 3235494T3 PL 15870365 T PL15870365 T PL 15870365T PL 15870365 T PL15870365 T PL 15870365T PL 3235494 T3 PL3235494 T3 PL 3235494T3
- Authority
- PL
- Poland
- Prior art keywords
- active ingredient
- preparation containing
- transdermal preparation
- containing donepezil
- donepezil
- Prior art date
Links
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 229960003530 donepezil Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20140183446 | 2014-12-18 | ||
| EP15870365.2A EP3235494B1 (en) | 2014-12-18 | 2015-12-18 | Transdermal preparation containing donepezil as active ingredient |
| PCT/KR2015/013940 WO2016099198A1 (ko) | 2014-12-18 | 2015-12-18 | 도네페질을 유효성분으로 함유하는 경피흡수제제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3235494T3 true PL3235494T3 (pl) | 2020-08-24 |
Family
ID=56126987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15870365T PL3235494T3 (pl) | 2014-12-18 | 2015-12-18 | Preparat transdermalny zawierający donepezil jako składnik aktywny |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10888533B2 (pl) |
| EP (1) | EP3235494B1 (pl) |
| JP (1) | JP6793648B2 (pl) |
| KR (1) | KR101796771B1 (pl) |
| CN (2) | CN113797180A (pl) |
| AU (1) | AU2015363883B2 (pl) |
| CA (1) | CA2970276C (pl) |
| DK (1) | DK3235494T3 (pl) |
| ES (1) | ES2786399T3 (pl) |
| HU (1) | HUE048569T2 (pl) |
| MY (1) | MY181540A (pl) |
| PL (1) | PL3235494T3 (pl) |
| PT (1) | PT3235494T (pl) |
| RU (1) | RU2713207C2 (pl) |
| WO (1) | WO2016099198A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL260290B2 (en) | 2015-12-30 | 2023-11-01 | Corium Inc | Systems and methods for long-term percutaneous administration |
| US11541018B2 (en) | 2016-06-23 | 2023-01-03 | Corium, Llc | Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent |
| JP7153010B2 (ja) | 2016-07-27 | 2022-10-13 | コリウム， インコーポレイテッド | 塩薬物のｉｎ ｓｉｔｕでの塩から中性の薬物変換による、低溶解度または不安定非イオン化中性薬物の経皮配合物および送達方法 |
| CN109789134A (zh) | 2016-07-27 | 2019-05-21 | 考里安国际公司 | 与口服递送药代动力学生物等效的透皮递送系统 |
| MX2019001104A (es) | 2016-07-27 | 2019-10-02 | Corium Int Inc | Sistemas de suministro transdermico de memantina. |
| KR102033686B1 (ko) | 2017-05-19 | 2019-10-18 | 보령제약 주식회사 | 도네페질을 함유하는 마이크로니들 경피 패치 |
| KR102904873B1 (ko) * | 2017-07-26 | 2025-12-29 | 코리움, 엘엘씨 | 용매가 채워진 공극을 가진 미세다공성 막을 구비한 경피 전달 시스템 |
| CA3086163A1 (en) | 2017-12-20 | 2019-06-27 | Corium, Inc. | Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point |
| KR102024996B1 (ko) * | 2017-12-27 | 2019-09-25 | 동아에스티 주식회사 | 도네페질을 함유하는 치매 치료용 경피흡수제제 |
| KR102115102B1 (ko) | 2018-12-21 | 2020-05-26 | 동아에스티 주식회사 | 안정화된 도네페질 함유 경피 흡수제제 |
| KR102709239B1 (ko) | 2021-10-20 | 2024-09-25 | 서울대학교병원 | 치매 약물의 부작용을 평가할 수 있는 치매 약물 패치 |
| KR20240146479A (ko) * | 2023-03-29 | 2024-10-08 | 아이큐어 주식회사 | 고용량 도네페질 약물탑재 지속방출 경피흡수제제 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
| JP3987655B2 (ja) | 1998-03-03 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
| EP1366762B1 (en) * | 2001-03-07 | 2015-12-30 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
| US20040258741A1 (en) | 2001-10-17 | 2004-12-23 | Takaaki Terahara | Percutaneous absorption preparations |
| JP5110712B2 (ja) * | 2006-12-01 | 2012-12-26 | 日東電工株式会社 | ドネペジル含有貼付製剤の経時的な変色を抑制する方法 |
| KR101454362B1 (ko) * | 2008-03-24 | 2014-10-23 | 아이큐어 주식회사 | 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제 |
| US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| AU2009300184A1 (en) * | 2008-09-30 | 2010-04-08 | Teikoku Pharma Usa, Inc. | Transdermal extended-delivery donepezil compositions and methods for using the same |
| US8456368B2 (en) * | 2009-01-27 | 2013-06-04 | Casio Computer Co., Ltd. | Antenna device and radio-wave receiver with such antenna device |
| US20100209484A1 (en) * | 2009-02-13 | 2010-08-19 | Hoo-Kyun Choi | Transdermal Triptan Delivery System |
| KR101325104B1 (ko) * | 2009-09-16 | 2013-11-07 | 주식회사 삼양바이오팜 | 경피 투여 제형 및 그 제조 방법 |
| JP2012236773A (ja) * | 2009-12-16 | 2012-12-06 | Goto Takeshi | 抗認知症薬物の経皮吸収製剤 |
| US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| NZ605352A (en) * | 2010-06-30 | 2013-10-25 | Nal Pharmaceuticals Ltd | Process for producing glycosaminoglycans |
| TWI433904B (zh) * | 2011-01-12 | 2014-04-11 | Taiwan Biotech Co Ltd | 多奈哌齊經皮貼片 |
| KR101395557B1 (ko) * | 2011-08-25 | 2014-05-16 | 아이큐어 주식회사 | 경피 흡수 제제 및 그 제조방법 |
| KR101239150B1 (ko) | 2012-02-28 | 2013-03-06 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
| US9539201B2 (en) * | 2012-04-20 | 2017-01-10 | KAT Transdermals LLC | Selegiline transdermal system |
| CN102895217A (zh) * | 2012-11-13 | 2013-01-30 | 沈阳药科大学 | 长效多奈哌齐经皮吸收贴剂 |
| KR101770675B1 (ko) * | 2013-01-30 | 2017-08-23 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
| CN108123793A (zh) * | 2017-12-19 | 2018-06-05 | 杭州中天微系统有限公司 | 基于apb总线的spi通信装置 |
-
2015
- 2015-12-18 MY MYPI2017702165A patent/MY181540A/en unknown
- 2015-12-18 EP EP15870365.2A patent/EP3235494B1/en active Active
- 2015-12-18 HU HUE15870365A patent/HUE048569T2/hu unknown
- 2015-12-18 CN CN202111197382.8A patent/CN113797180A/zh active Pending
- 2015-12-18 PT PT158703652T patent/PT3235494T/pt unknown
- 2015-12-18 AU AU2015363883A patent/AU2015363883B2/en active Active
- 2015-12-18 CN CN201580069780.8A patent/CN107106510A/zh active Pending
- 2015-12-18 RU RU2017125361A patent/RU2713207C2/ru active
- 2015-12-18 WO PCT/KR2015/013940 patent/WO2016099198A1/ko not_active Ceased
- 2015-12-18 ES ES15870365T patent/ES2786399T3/es active Active
- 2015-12-18 JP JP2017533482A patent/JP6793648B2/ja active Active
- 2015-12-18 PL PL15870365T patent/PL3235494T3/pl unknown
- 2015-12-18 KR KR1020150181809A patent/KR101796771B1/ko active Active
- 2015-12-18 DK DK15870365.2T patent/DK3235494T3/da active
- 2015-12-18 CA CA2970276A patent/CA2970276C/en active Active
-
2017
- 2017-06-16 US US15/625,054 patent/US10888533B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017538771A (ja) | 2017-12-28 |
| DK3235494T3 (da) | 2020-03-02 |
| MY181540A (en) | 2020-12-28 |
| CA2970276A1 (en) | 2016-06-23 |
| EP3235494A4 (en) | 2018-08-15 |
| JP6793648B2 (ja) | 2020-12-02 |
| PT3235494T (pt) | 2020-03-05 |
| ES2786399T3 (es) | 2020-10-09 |
| EP3235494B1 (en) | 2019-11-27 |
| RU2713207C2 (ru) | 2020-02-04 |
| AU2015363883A1 (en) | 2017-06-29 |
| RU2017125361A3 (pl) | 2019-07-17 |
| BR112017012951A2 (pt) | 2018-03-06 |
| CN107106510A (zh) | 2017-08-29 |
| RU2017125361A (ru) | 2019-01-18 |
| WO2016099198A1 (ko) | 2016-06-23 |
| CA2970276C (en) | 2023-08-01 |
| AU2015363883B2 (en) | 2021-03-25 |
| HUE048569T2 (hu) | 2020-07-28 |
| US20170290780A1 (en) | 2017-10-12 |
| EP3235494A1 (en) | 2017-10-25 |
| KR101796771B1 (ko) | 2017-11-10 |
| CN113797180A (zh) | 2021-12-17 |
| KR20160074433A (ko) | 2016-06-28 |
| US10888533B2 (en) | 2021-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3235494T (pt) | Preparação transdérmica contendo donepezilo como ingrediente ativo | |
| IL253123B (en) | Preparations for administration through the skin and their uses | |
| IL248984A0 (en) | Transdermal cream | |
| ZA201605855B (en) | Agrochemical composition for foliage treatment | |
| GB201516729D0 (en) | Liquid nicotine formulation | |
| SG11201702298VA (en) | Pharmaceutical preparation | |
| IL252062A0 (en) | Transdermal compositions | |
| EP3096745A4 (en) | Transdermal delivery system comprising donepezil or its salt | |
| IL251059B (en) | Arimoclomol formulation | |
| IL273087A (en) | Transdermal compositions | |
| SG11201610636VA (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| PL3184492T3 (pl) | Preparat antyseptyczny | |
| IL249010A0 (en) | A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient | |
| SG11201608845PA (en) | Cosmetic composition containing mentha haplocalyx as active ingredient | |
| EP3100721A4 (en) | Capsule formulation | |
| EP3107532A4 (en) | Transdermal drug delivery system containing donepezil | |
| IL258675A (en) | Mosquito repellent compounds | |
| EP3181125A4 (en) | Capsule formulation | |
| IL258295A (en) | Fviii formulation | |
| EP3299012A4 (en) | Transdermal liquid preparation | |
| EP3150205A4 (en) | Transdermal preparation | |
| ZA201500995B (en) | Low dose pharmaceutical composition | |
| GB201417589D0 (en) | Pharmaceutical Formulations | |
| EP3441068A4 (en) | TRANSDERMALES PREPARATION | |
| EP3305312A4 (en) | EXTERNAL PREPARATION FOR TRANSDERMAL ADMINISTRATION |